Treatment decisions and discontinuation of palliative chemotherapy near the end-of-life, in relation to socioeconomic variables

References

• Bergh J. Quo vadis with targeted drugs in the 21st century? J Clin Oncol 2009;27:2–5.
   PubMed Web of Science ®Google Scholar
• Hudis CA. Trastuzumab – mechanism of action and use in clinical practice. N Engl J Med 2007;357:39–51.
   PubMed Web of Science ®Google Scholar
• Andre F, Slimane K, Bachelot T, Dunant A, Namer M, Barrelier A, et al. Breast cancer with synchronous metastases: Trends in survival during a 14-year period. J Clin Oncol 2004;22:3302–8.
   PubMed Web of Science ®Google Scholar
• Renouf D, Kennecke H, Gill S. Trends in chemotherapy utilization for colorectal cancer. Clin Colorectal Cancer 2008;7:386–9.
   PubMed Web of Science ®Google Scholar
• Cancerfonden. Cancerfondsrapporten (Swe). Stockholm: The Swedish Cancer Society; 2011. pp. 132.
   Google Scholar
• Earle CC, Neville BA, Landrum MB, Ayanian JZ, Block SD, Weeks JC. Trends in the aggressiveness of cancer care near the end of life. J Clin Oncol 2004;22:315–21.
   PubMed Web of Science ®Google Scholar
• Nappa U, Lindqvist O, Rasmussen BH, Axelsson B. Palliative chemotherapy during the last month of life. Ann Oncol 2011;22:2375–80.
   PubMed Web of Science ®Google Scholar
• Emanuel EJ, Young-Xu Y, Levinsky NG, Gazelle G, Saynina O, Ash AS. Chemotherapy use among Medicare beneficiaries at the end of life. Ann Intern Med 2003;138:639–43.
   PubMed Web of Science ®Google Scholar
• Christakis NA, Lamont EB. Extent and determinants of error in doctors’ prognoses in terminally ill patients: Prospective cohort study. BMJ 2000;320:469–72.
   PubMed Web of Science ®Google Scholar
• Harrington SE, Smith TJ. The role of chemotherapy at the end of life: “When is enough, enough?” JAMA 2008;299:2667–78.
   PubMed Web of Science ®Google Scholar
• Murillo JR, Jr., Koeller J. Chemotherapy given near the end of life by community oncologists for advanced non-small cell lung cancer. Oncologist 2006;11:1095–9.
   PubMed Web of Science ®Google Scholar
• Browner I, Carducci MA. Palliative chemotherapy: Historical perspective, applications, and controversies. Semin Oncol 2005;32:145–55.
   PubMed Web of Science ®Google Scholar
• Chochinov HM, Tataryn DJ, Wilson KG, Ennis M, Lander S. Prognostic awareness and the terminally ill. Psychosomatics 2000;41:500–4.
   PubMed Web of Science ®Google Scholar
• Chu DT, Kim SW, Kuo HP, Ozacar R, Salajka F, Krishnamurthy S, et al. Patient attitudes towards chemotherapy as assessed by patient versus physician: A prospective observational study in advanced non-small cell lung cancer. Lung Cancer 2007;56:433–43.
   PubMed Web of Science ®Google Scholar
• Matsuyama R, Reddy S, Smith TJ. Why do patients choose chemotherapy near the end of life? A review of the perspective of those facing death from cancer. J Clin Oncol 2006;24:3490–6.
   PubMed Web of Science ®Google Scholar
• Saviani-Zeoti F, Petean EB. Breaking bad news: Doctors’ feelings and behaviors. Span J Psychol 2007;10:380–7.
   PubMed Web of Science ®Google Scholar
• Bernheim SM, Ross JS, Krumholz HM, Bradley EH. Influence of patients’ socioeconomic status on clinical management decisions: A qualitative study. Ann Fam Med 2008;6:53–9.
   PubMed Web of Science ®Google Scholar
• Byers TE, Wolf HJ, Bauer KR, Bolick-Aldrich S, Chen VW, Finch JL, et al. The impact of socioeconomic status on survival after cancer in the United States: Findings from the National Program of Cancer Registries Patterns of Care Study. Cancer 2008;113:582–91.
   PubMed Web of Science ®Google Scholar
• Cavalli-Bjorkman N, Lambe M, Eaker S, Sandin F, Glimelius B. Differences according to educational level in the management and survival of colorectal cancer in Sweden. Eur J Cancer 2011;47:1398–406.
   PubMed Web of Science ®Google Scholar
• Albano JD, Ward E, Jemal A, Anderson R, Cokkinides VE, Murray T, et al. Cancer mortality in the United States by education level and race. J Natl Cancer Inst 2007;99: 1384–94.
   PubMed Web of Science ®Google Scholar
• Walston J, Hadley EC, Ferrucci L, Guralnik JM, Newman AB, Studenski SA, et al. Research agenda for frailty in older adults: Toward a better understanding of physiology and etiology: Summary from the American Geriatrics Society/National Institute on Aging Research Conference on Frailty in Older Adults. J Am Geriatr Soc 2006;54:991–1001.
   PubMed Web of Science ®Google Scholar
• Cavalli-Bjorkman N, Glimelius B, Strang P. Equal cancer treatment regardless of education level and family support? A qualitative study of oncologists’ decision-making. BMJ Open 2012;2:e001248.
   Google Scholar
• Singer T. The past, present and future of social neuroscience: A European perspective. Neuroimage 2012;61:437–49.
   PubMed Web of Science ®Google Scholar
• Dapretto M, Davies MS, Pfeifer JH, Scott AA, Sigman M, Bookheimer SY, et al. Understanding emotions in others: Mirror neuron dysfunction in children with autism spectrum disorders. Nat Neurosci 2006;9:28–30.
   PubMed Web of Science ®Google Scholar
• Rizzolatti G. The mirror neuron system and its function in humans. Anat Embryol (Berl) 2005;210:419–21.
   PubMedGoogle Scholar
• Street RL, Jr., O’Malley KJ, Cooper LA, Haidet P. Understanding concordance in patient-physician relationships: Personal and ethnic dimensions of shared identity. Ann Fam Med 2008;6:198–205.
   PubMed Web of Science ®Google Scholar
• Chang SM, Barker FG, 2nd. Marital status, treatment, and survival in patients with glioblastoma multiforme: A population based study. Cancer 2005;104:1975–84.
   PubMed Web of Science ®Google Scholar
• Pinquart M, Duberstein PR. Associations of social networks with cancer mortality: A meta-analysis. Crit Rev Oncol Hematol 2010;75:122–37.
   PubMed Web of Science ®Google Scholar
• Bhargava A, Du XL. Racial and socioeconomic disparities in adjuvant chemotherapy for older women with lymph node-positive, operable breast cancer. Cancer 2009;115: 2999–3008.
   PubMed Web of Science ®Google Scholar
• Obeidat NA, Pradel FG, Zuckerman IH, Trovato JA, Palumbo FB, DeLisle S, et al. Racial/ethnic and age disparities in chemotherapy selection for colorectal cancer. Am J Manag Care 2010;16:515–22.
   PubMed Web of Science ®Google Scholar
• Weeks JC, Catalano PJ, Cronin A, Finkelman MD, Mack JW, Keating NL, et al. Patients’ expectations about effects of chemotherapy for advanced cancer. N Engl J Med 2012;367:1616–25.
   PubMed Web of Science ®Google Scholar
• Back AL, Arnold RM, Baile WF, Tulsky JA, Fryer-Edwards K. Approaching difficult communication tasks in oncology. CA Cancer J Clin 2005;55:164–77.
   PubMed Web of Science ®Google Scholar
• Baider L, Wein S. Reality and fugues in physicians facing death: Confrontation, coping, and adaptation at the bedside. Crit Rev Oncol Hematol 2001;40:97–103.
   PubMed Web of Science ®Google Scholar
• Ptacek JT, Eberhardt TL. Breaking bad news. A review of the literature. JAMA 1996;276:496–502.
   PubMed Web of Science ®Google Scholar